For decades, pharmaceutical companies have used animal testing and clinical trials to determine the effectiveness and safety of new drug formulas.
But these methods have proved to be costly, dangerous and highly inefficient. To fix this, global biotech firm Novoheart has developed the world’s first miniature beating human hearts using stem cells.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,